Expert consensus statement on Xiyanping Injection for respiratory system infectious diseases in clinical practice(adults).
10.19540/j.cnki.cjcmm.20191105.502
- Author:
Zhi-Fei WANG
1
;
Hong-Chun ZHANG
2
;
Yan-Ming XIE
1
;
Qing MIAO
3
;
Zeng-Tao SUN
4
;
Rong-Bing WANG
5
;
Xiao-Ge WANG
6
;
Si-Yan ZHAN
7
Author Information
1. Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
2. China-Japan Friendship Hospital Beijing 100029,China.
3. Xiyuan Hospital,China Academy of Chinese Medical Sciences Beijing 100091,China.
4. Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Tianjin 300150,China.
5. Beijing Ditan Hospital Affiliated to Capital Medical University Beijing 100015,China.
6. the Fourth Affiliated Hospital of China Medical University Shenyang 110032,China.
7. School of Public Health,Peking University Beijing 100191,China.
- Publication Type:Journal Article
- Keywords:
Xiyanping Injection;
classification of evidence;
clinical practice;
expert consensus statement;
recommendation
- MeSH:
Adult;
Consensus;
Drugs, Chinese Herbal/therapeutic use*;
Humans;
Medicine, Chinese Traditional;
Respiratory Tract Infections/drug therapy*
- From:
China Journal of Chinese Materia Medica
2019;44(24):5282-5286
- CountryChina
- Language:Chinese
-
Abstract:
Xiyanping Injection is widely used in the treatment of respiratory infectious diseases. However,its package insert is still less instructive for physicians in understanding the specific clinical application of Xiyanping Injection. To discover potential clinical advantages of Xiyanping Injection,the team invited clinical experts of traditional Chinese medicine and western medicine from the field of respiratory diseases,pharmacists and methodologists of evidence-based medicine to compile the consensus. The consensus was based on a combination of clinical research evidence and expert experience,involving recommendations for clinical problems supported by clini-cal evidence as well as consensus suggestions for clinical problems with no clinical evidence. The consensus recommended the indication,timing of intervention,usage,dosage,course of treatment,combined medication of Xiyanping Injection used for adults,and introduced the safety and precautions of its clinical application. It is suitable for guiding clinical medical workers to rationally use Xiyanping Injection in the treatment of adult's respiratory infectious diseases.
